Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
56
NEOG Quote, Financials, Valuation and Earnings
Last price:
$9.25
Seasonality move
:
-2.9%
Day range:
$9.19 - $9.59
52-week range:
$3.87 - $12.07
Dividend yield:
0%
P/E ratio:
2,124.15x
P/S ratio:
2.28x
P/B ratio:
0.96x
Volume:
2M
Avg. volume:
4.3M
1-year change:
-20.26%
Market cap:
$2B
Revenue:
$894.7M
EPS (TTM):
-$2.78
Analysts' Opinion
-
Consensus RatingNeogen Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $11.67, Neogen Corp. has an estimated upside of 26.13% from its current price of $9.25.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.00 representing 100% downside risk from its current price of $9.25.
Fair Value
-
According to the consensus of 3 analysts, Neogen Corp. has 26.13% upside to fair value with a price target of $11.67 per share.
NEOG vs. S&P 500
-
Over the past 5 trading days, Neogen Corp. has underperformed the S&P 500 by -3.48% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Neogen Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Neogen Corp. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Neogen Corp. reported revenues of $224.7M.
Earnings Growth
-
Neogen Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Neogen Corp. reported earnings per share of -$0.07.
Enterprise value:
2.7B
EV / Invested capital:
0.92x
Price / LTM sales:
2.28x
EV / EBIT:
443.04x
EV / Revenue:
3.02x
PEG ratio (5yr expected):
-0.13x
EV / Free cash flow:
-129.79x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
25.00x
Gross Profit (TTM):
$312.1M
Return On Assets:
-16.46%
Net Income Margin (TTM):
-68.47%
Return On Equity:
-25.93%
Return On Invested Capital:
-18.95%
Operating Margin:
0.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-11-30 | 2024-11-30 | 2025-11-30 | 2024-11-30 | 2025-11-30 | |
| Income Statement | ||||||
| Revenue | $918.7M | $913.8M | $880.3M | $231.3M | $224.7M | |
| Gross Profit | $464.7M | $405.3M | $312.1M | $89.7M | $83.8M | |
| Operating Income | $79.2M | $55M | -$11.2M | $17.1M | $748K | |
| EBITDA | $193.3M | $173.4M | $106.4M | $47.1M | $29.7M | |
| Diluted EPS | $0.05 | -$2.20 | -$2.78 | -$2.10 | -$0.07 | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $611.2M | $643.3M | $624.4M | $570.4M | $574.6M | |
| Total Assets | $967.9M | $4.6B | $4.6B | $4.1B | $3.4B | |
| Current Liabilities | $62.7M | $152.6M | $176.6M | $151.2M | $147.1M | |
| Total Liabilities | $102.5M | $1.5B | $1.5B | $1.4B | $1.3B | |
| Total Equity | $865.5M | $3.1B | $3.1B | $2.7B | $2.1B | |
| Total Debt | -- | $924M | $889.5M | $892.4M | $792.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-11-30 | 2024-11-30 | 2025-11-30 | 2024-11-30 | 2025-11-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $112.2M | $18.7M | $64.2M | $40.3M | $19.4M | |
| Cash From Investing | $29.3M | -$83M | $37.7M | -$17.2M | -$11.7M | |
| Cash From Financing | -$38.6M | $885K | -$99M | -$1.4M | -$451K | |
| Free Cash Flow | $16.5M | -$93.2M | -$20.5M | $23.1M | $7.8M | |
NEOG
Sector
Market Cap
$2B
$26.2M
Price % of 52-Week High
76.64%
51.54%
Dividend Yield
0%
0%
Shareholder Yield
1.37%
-1.64%
1-Year Price Total Return
-20.26%
-16.92%
Beta (5-Year)
1.956
0.489
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$9.17
200-day SMA
Buy
Level
$5.94
Bollinger Bands (100)
Buy
Level
5.37 - 7.37
Chaikin Money Flow
Buy
Level
180.4M
20-day SMA
Buy
Level
$7.98
Relative Strength Index (RSI14)
Buy
Level
71.56
ADX Line
Buy
Level
42.58
Williams %R
Neutral
Level
-30.7918
50-day SMA
Buy
Level
$6.92
MACD (12, 26)
Buy
Level
0.76
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Sell
Level
-186.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7285)
Buy
CA Score
(Annual)
Level (0.3036)
Buy
Beneish M-Score
(Annual)
Level (-4.2388)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.8686)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Stock Forecast FAQ
In the current month, NEOG has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The NEOG average analyst price target in the past 3 months is $11.67.
-
Where Will Neogen Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Neogen Corp. share price will rise to $11.67 per share over the next 12 months.
-
What Do Analysts Say About Neogen Corp.?
Analysts are divided on their view about Neogen Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Neogen Corp. is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is Neogen Corp.'s Price Target?
The price target for Neogen Corp. over the next 1-year time period is forecast to be $11.67 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is NEOG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Neogen Corp. is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of NEOG?
You can purchase shares of Neogen Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Neogen Corp. shares.
-
What Is The Neogen Corp. Share Price Today?
Neogen Corp. was last trading at $9.25 per share. This represents the most recent stock quote for Neogen Corp.. Yesterday, Neogen Corp. closed at $9.25 per share.
-
How To Buy Neogen Corp. Stock Online?
In order to purchase Neogen Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get NEOG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NEOG
Sector
P/E ratio
2,124.15x
23.89x
PEG ratio
-0.13x
-0.01x
P/B ratio
0.96x
1.81x
Price / LTM sales
2.28x
1.59x
Growth Metrics
NEOG
Sector
Revenue growth
-2.84%
4.35%
Earnings growth
96.52%
9.8%
Revenue (5-year growth)
16.43%
6.41%
Earnings forecast
$0.07
-$0.18
Profitability
NEOG
Sector
Profitability FY 2025
$421.4M
$3.2M
Return on invested capital
-18.95%
-32.76%
Return on assets
-16.46%
-29.32%
Return on equity
-25.93%
-38.6%
Earnings Date
Last Earnings Date
Jan
8
Next Earnings Date
Apr
8
Estimated Next Earnings Date
Apr
9
Balance Sheet
NEOG
Sector
Total cash
$145.3M
$25.4M
Short term investments
--
$25.1M
Total assets
$3.5B
$74.7M
Long term debt
$792.9M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
